Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-22-003495

Options or other derivatives

  • President and CEO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sooch Mina President and CEO 2022-01-28 Grant or award · Employee Stock Option (right to buy) +200,000 200,000 D: show line 1 in the form
Loading xslF345X03/form4.xml…